Schedule 13G ownership disclosure
PDL BIOPHARMA INC
Security class unavailable · CUSIP: 69329Y104
Event date: 2020-12-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905718-21-000037
- Form type
- SC 13G
- Filer
- PDL BIOPHARMA, INC.
- CIK
- CIK 882104
- Filed
- Jan 11, 2021
- Reporting period
- Dec 30, 2020
- Description
- Schedule 13G beneficial ownership